PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10715359-0 2000 Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Yohimbine 17-26 neuropeptide Y Homo sapiens 45-59 14625151-2 2003 We previously reported that baseline plasma neuropeptide-Y levels, as well as neuropeptide-Y responses to yohimbine, were lower in combat veterans with posttraumatic stress disorder, but we were unable to determine whether this was attributable to posttraumatic stress disorder or trauma exposure. Yohimbine 106-115 neuropeptide Y Homo sapiens 78-92 19233186-4 2009 Stimulation of food intake caused by neuropeptide Y and beta-endorphin was attenuated by co-injection with yohimbine. Yohimbine 107-116 neuropeptide Y Homo sapiens 37-51 10715359-0 2000 Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Yohimbine 17-26 neuropeptide Y Homo sapiens 61-64 10715359-3 2000 METHODS: In the following study, plasma NPY responses to yohimbine and placebo were measured in a subgroup of 18 subjects with PTSD and 8 healthy control subjects who participated in the previous study of the effect of yohimbine on plasma MHPG. Yohimbine 57-66 neuropeptide Y Homo sapiens 40-43 10715359-4 2000 RESULTS: The PTSD subjects had lower baseline plasma NPY and blunted yohimbine-stimulated increases in plasma NPY compared with the healthy control subjects. Yohimbine 69-78 neuropeptide Y Homo sapiens 110-113 9608581-0 1998 Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine. Yohimbine 86-95 neuropeptide Y Homo sapiens 7-21 9608581-0 1998 Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine. Yohimbine 86-95 neuropeptide Y Homo sapiens 23-26 9608581-2 1998 We herein report that yohimbine also increases plasma neuropeptide Y (NPY) in healthy human subjects. Yohimbine 22-31 neuropeptide Y Homo sapiens 54-68 9608581-2 1998 We herein report that yohimbine also increases plasma neuropeptide Y (NPY) in healthy human subjects. Yohimbine 22-31 neuropeptide Y Homo sapiens 70-73 9608581-7 1998 This study therefore suggests that yohimbine challenge may be useful in assessing NPY and noradrenergic system interactions in neuropsychiatric disorders such as panic disorder or post traumatic stress disorder in which noradrenergic system dysfunction has been observed. Yohimbine 35-44 neuropeptide Y Homo sapiens 82-85 2170253-11 1990 Many classical pharmacological agents including guanethidine, clonidine, yohimbine, angiotensin II, nicotine and desipramine influence NPY release. Yohimbine 73-82 neuropeptide Y Homo sapiens 135-138